Literature DB >> 11976265

Identification of the monomeric G-protein, Rhes, as an efaroxan-regulated protein in the pancreatic beta-cell.

Sue L F Chan1, Lara K Monks, Hongwei Gao, Pamela Deaville, Noel G Morgan.   

Abstract

Efaroxan induces membrane depolarization by interaction with the pore forming subunit of the ATP-sensitive potassium channel, Kir6.2. However, this effect is not responsible for its full secretory activity. In this study we have used an anti-idiotypic approach to generate antibodies that recognize additional proteins that may be regulated by efaroxan in pancreatic beta-cells. Using these antisera in an expression cloning strategy we have identified a monomeric GTP-binding protein, Rhes, as a potential target for regulation by imidazoline ligands. Rhes is shown to be expressed in beta-cells and its expression is regulated by efaroxan under conditions when a structurally related molecule, KU14R, is ineffective. The results reveal that beta-cells express Rhes and suggest that changes in the expression of this molecule may regulate the sensitivity of beta-cells to imidazoline secretagogues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11976265      PMCID: PMC1762110          DOI: 10.1038/sj.bjp.0704680

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Dexras1/AGS-1, a steroid hormone-induced guanosine triphosphate-binding protein, inhibits 3',5'-cyclic adenosine monophosphate-stimulated secretion in AtT-20 corticotroph cells.

Authors:  T E Graham; T A Key; K Kilpatrick; R I Dorin
Journal:  Endocrinology       Date:  2001-06       Impact factor: 4.736

2.  Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan.

Authors:  S L Chan; M Mourtada; N G Morgan
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

3.  Specific desensitization of sulfonylurea- but not imidazoline-induced insulin release after prolonged tolbutamide exposure.

Authors:  N H McClenaghan; A J Ball; P R Flatt
Journal:  Biochem Pharmacol       Date:  2001-03-01       Impact factor: 5.858

Review 4.  Imidazoline binding sites in the endocrine pancreas: can they fulfil their potential as targets for the development of new insulin secretagogues?

Authors:  N G Morgan; S L Chan
Journal:  Curr Pharm Des       Date:  2001-09       Impact factor: 3.116

5.  The imidazoline RX871024 stimulates insulin secretion in pancreatic beta-cells from mice deficient in K(ATP) channel function.

Authors:  A M Efanov; M Høy; R Bränström; S V Zaitsev; M A Magnuson; S Efendic; J Gromada; P O Berggren
Journal:  Biochem Biophys Res Commun       Date:  2001-06-22       Impact factor: 3.575

6.  Auto-anti-idiotype: a basis for autoimmunity and a strategy for anti-receptor antibodies.

Authors:  B F Erlanger; W L Cleveland; N H Wassermann; H H Ku; B L Hill; R Sarangarajan; R Rajagopalan; E Cayanis; I S Edelman; A S Penn
Journal:  Immunol Rev       Date:  1986-12       Impact factor: 12.988

7.  ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.

Authors:  J C Chapman; N H McClenaghan; K E Cosgrove; M N Hashmi; R M Shepherd; A N Giesberts; S J White; C Ammälä; P R Flatt; M J Dunne
Journal:  Diabetes       Date:  1999-12       Impact factor: 9.461

8.  Glucose-induced insulin secretion is potentiated by a new imidazoline compound.

Authors:  H J Mest; A Raap; J Schloos; I Treinies; M Paal; U Giese; V Koivisto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-07       Impact factor: 3.000

9.  Rhes: A striatal-specific Ras homolog related to Dexras1.

Authors:  J D Falk; P Vargiu; P E Foye; H Usui; J Perez; P E Danielson; D L Lerner; J Bernal; J G Sutcliffe
Journal:  J Neurosci Res       Date:  1999-09-15       Impact factor: 4.164

10.  The novel imidazoline compound BL11282 potentiates glucose-induced insulin secretion in pancreatic beta-cells in the absence of modulation of K(ATP) channel activity.

Authors:  A M Efanov; S V Zaitsev; H J Mest; A Raap; I B Appelskog; O Larsson; P O Berggren; S Efendic
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

View more
  5 in total

Review 1.  Small G proteins in islet beta-cell function.

Authors:  Anjaneyulu Kowluru
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

Review 2.  Rhes: a GTP-binding protein integral to striatal physiology and pathology.

Authors:  Laura M Harrison
Journal:  Cell Mol Neurobiol       Date:  2012-03-27       Impact factor: 5.046

Review 3.  Human RAS superfamily proteins and related GTPases.

Authors:  John Colicelli
Journal:  Sci STKE       Date:  2004-09-07

4.  Farnesylation or geranylgeranylation? Efficient assays for testing protein prenylation in vitro and in vivo.

Authors:  Wolfgang Benetka; Manfred Koranda; Sebastian Maurer-Stroh; Fritz Pittner; Frank Eisenhaber
Journal:  BMC Biochem       Date:  2006-02-28       Impact factor: 4.059

Review 5.  Small G Proteins Dexras1 and RHES and Their Role in Pathophysiological Processes.

Authors:  Ashish Thapliyal; Rashmi Verma; Navin Kumar
Journal:  Int J Cell Biol       Date:  2014-03-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.